Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry

Show simple item record

dc.contributor.author Kraft, Magdalena
dc.contributor.author Knop, Macarena Pia
dc.contributor.author Renaudin, Jean-Marie
dc.contributor.author Scherer Hofmeier, Kathrin
dc.contributor.author Pföhler, Claudia
dc.contributor.author Bilò, Maria Beatrice
dc.contributor.author Lang, Roland
dc.contributor.author Treudler, Regina
dc.contributor.author Wagner, Nicola
dc.contributor.author Spindler, Thomas
dc.contributor.author Hourihane, Jonathan O'B.
dc.contributor.author Maris, Ioana
dc.contributor.author Koehli, Alice
dc.contributor.author Bauer, Andrea
dc.contributor.author Lange, Lars
dc.contributor.author Müller, Sabine
dc.contributor.author Papadopoulos, Nikolaos G.
dc.contributor.author Wedi, Bettina
dc.contributor.author Moeser, Anne
dc.contributor.author Ensina, Luis F.
dc.contributor.author Fernandez-Rivas, Montserrat
dc.contributor.author Cichocka-Jarosz, Ewa
dc.contributor.author Christoff, George
dc.contributor.author Garcia, Blanca E.
dc.contributor.author Poziomkowska-Gęsicka, Iwona
dc.contributor.author Cardona, Victoria
dc.contributor.author Mustakov, Tihomir B.
dc.contributor.author Rabe, Uta
dc.contributor.author Mahler, Vera
dc.contributor.author Grabenhenrich, Linus
dc.contributor.author Dölle-Bierke, Sabine
dc.contributor.author Worm, Margitta
dc.date.accessioned 2019-12-09T09:38:22Z
dc.date.available 2019-12-09T09:38:22Z
dc.date.issued 2019-10-04
dc.identifier.citation Kraft, M., Knop, M. P., Renaudin, J.-M., Scherer Hofmeier, K., Pföhler, C., Bilò, M. B., Lang, R., Treudler, R., Wagner, N., Spindler, T., Hourihane, J. O. B., Maris, I., Koehli, A., Bauer, A., Lange, L., Müller, S., Papadopoulos, N. G., Wedi, B., Moeser, A., Ensina, L. F., Fernandez-Rivas, M., Cichocka-Jarosz, E., Christoff, G., Garcia, B. E., Poziomkowska-Gęsicka, I., Cardona, V., Mustakov, T. B., Rabe, U., Mahler, V., Grabenhenrich, L., Dölle-Bierke, S., Worm, M. and Anaphylaxis, T. N. f. O. R. o. 'Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry', Allergy, [in press]. (10pp.) doi: 10.1111/all.14069 en
dc.identifier.startpage 1 en
dc.identifier.endpage 10 en
dc.identifier.issn 0105-4538
dc.identifier.uri http://hdl.handle.net/10468/9352
dc.identifier.doi 10.1111/all.14069 en
dc.description.abstract Background: Patients with a history of anaphylaxis are at risk of future anaphylactic reactions. Thus, secondary prevention measures are recommended for these patients to prevent or attenuate the next reaction. Methods: Data from the Anaphylaxis Registry were analyzed to identify secondary prevention measures offered to patients who experienced anaphylaxis. Our analysis included 7788 cases from 10 European countries and Brazil. Results:The secondary prevention measures offered varied across the elicitors. A remarkable discrepancy was observed between prevention measures offered in specialized allergy centers (84% of patients were prescribed adrenaline autoinjectors following EAACI guidelines) and outside the centers: Here, EAACI guideline adherence was only 37%. In the multivariate analysis, the elicitor of the reaction, age of the patient, mastocytosis as comorbidity, severity of the reaction, and reimbursement/availability of the autoinjector influence physician's decision to prescribe one. Conclusions: Based on the low implementation of guidelines concerning secondary prevention measures outside of specialized allergy centers, our findings highlight the importance of these specialized centers and the requirement of better education for primary healthcare and emergency physicians. en
dc.description.sponsorship Clinical Allergology Department PMU in Szczecin (WL‐151‐19) en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Blackwell Publishing Ltd en
dc.rights ©2019 The Authors. Allergy published by John Wiley & Sons Ltd.This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made en
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/ en
dc.subject Adrenaline autoinjector en
dc.subject Anaphylactic reaction en
dc.subject Anaphylaxis en
dc.subject Epinephrine autoinjector en
dc.subject Secondary prevention en
dc.title Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Jonathan Hourihane, INFANT, University College Cork, Cork, Ireland. +353-21-490-3000 Email:j.hourihane@ucc.ie en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.contributor.funder Pomorski Uniwersytet Medyczny W Szczecinie en
dc.contributor.funder The Network for Online Registration of Anaphylaxis en
dc.description.status Peer reviewed en
dc.identifier.journaltitle Allergy: European Journal of Allergy and Clinical Immunology en
dc.internal.IRISemailaddress j.hourihane@ucc.ie en
dc.internal.bibliocheck Check, vol, issue and article ID en


Files in this item

This item appears in the following Collection(s)

Show simple item record

©2019 The Authors. Allergy published by John Wiley & Sons Ltd.This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made Except where otherwise noted, this item's license is described as ©2019 The Authors. Allergy published by John Wiley & Sons Ltd.This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement